Entries by Maren Kühr

New CEO for Galapagos

Co-founder and former board member of Galapagos NV Dr Paul Stoffels will take over the position of Chief Executive Officer at the Belgian company from April. He succeeds long-time CEO Onno van de Stolpe, who is retiring.

Immunovia with acting CEO

Immunovia AB announces that Philipp Mathieu has been appointed as acting CEO and President with immediate effect. The search for a permanent CEO continues, as previously communicated.

Austria on the fast track

The Who’s Who of the biotech industry relies on Austria. Every second biotechnology company is located in the hotspot of Vienna, where a leading research centre – the Campus Vienna BioCenter – has emerged. Multinationals and startups benefit from an extensive value chain, from basic research to production and distribution. The national investment promotion agency Austrian Business Agency (ABA) is the first point of contact when making the leap into the Austrian market.